Todd Palmby, Ph.D. - Publications

Affiliations: 
2004 University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Molecular Biology, Cell Biology, Oncology

20 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Walker AJ, Wedam S, Amiri-Kordestani L, Bloomquist E, Tang S, Sridhara R, Chen W, Palmby TR, Fourie Zirkelbach J, Fu W, Liu Q, Tilley A, Kim G, Kluetz PG, McKee AE, et al. FDA Approval of Palbociclib in Combination with Fulvestrant for the Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27407089 DOI: 10.1158/1078-0432.CCR-16-0493  0.44
2016 Ison G, Beaver JA, McGuinn WD, Palmby TR, Dinin J, Charlab R, Marathe A, Jin R, Liu Q, Chen XH, Ysern X, Stephens O, Bai G, Wang Y, Dorff SE, et al. FDA Approval: Uridine Triacetate for the Treatment of Patients Following Fluorouracil or Capecitabine Overdose or Exhibiting Early-Onset Severe Toxicities Following Administration of These Drugs. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27401247 DOI: 10.1158/1078-0432.CCR-16-0638  0.44
2016 Dambach DM, Simpson NE, Jones TW, Brennan RJ, Pazdur R, Palmby TR. Nonclinical Evaluations of Small-Molecule Oncology Drugs: Integration into Clinical Dose Optimization and Toxicity Management. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 22: 2618-22. PMID 27250932 DOI: 10.1158/1078-0432.CCR-15-2645  0.44
2015 Beaver JA, Amiri-Kordestani L, Charlab R, Chen W, Palmby T, Tilley A, Fourie Zirkelbach J, Yu J, Liu Q, Zhao L, Crich J, Chen XH, Hughes M, Bloomquist E, Tang S, et al. FDA Approval: Palbociclib for the Treatment of Postmenopausal Patients with Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26324739 DOI: 10.1158/1078-0432.CCR-15-1185  0.44
2015 Kim G, Ison G, McKee AE, Zhang H, Tang S, Gwise T, Sridhara R, Lee E, Tzou A, Philip R, Chiu HJ, Ricks TK, Palmby T, Russell AM, Ladouceur G, et al. FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26187614 DOI: 10.1158/1078-0432.CCR-15-0887  0.44
2014 Amiri-Kordestani L, Blumenthal GM, Xu QCa, Zhang L, Tang SW, Ha L, Weinberg WC, Chi B, Candau-Chacon R, Hughes P, Russell AM, Miksinski SPo, Chen XHo, McGuinn WD, Palmby T, et al. FDA approval: ado-trastuzumab emtansine for the treatment of patients with HER2-positive metastatic breast cancer Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 4436-4441. PMID 24879797 DOI: 10.1158/1078-0432.CCR-14-0012  0.44
2014 Kluetz PG, Pierce W, Maher VE, Zhang H, Tang S, Song P, Liu Q, Haber MT, Leutzinger EE, Al-Hakim A, Chen W, Palmby T, Alebachew E, Sridhara R, Ibrahim A, et al. Radium Ra 223 dichloride injection: U.S. Food and Drug Administration drug approval summary. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 9-14. PMID 24190979 DOI: 10.1158/1078-0432.CCR-13-2665  0.44
2013 Kluetz PG, Ning YM, Maher VE, Zhang L, Tang S, Ghosh D, Aziz R, Palmby T, Pfuma E, Zirkelbach JF, Mehrotra N, Tilley A, Sridhara R, Ibrahim A, Justice R, et al. Abiraterone acetate in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer: U.S. Food and Drug Administration drug approval summary. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 6650-6. PMID 24150234 DOI: 10.1158/1078-0432.CCR-13-2134  0.44
2013 Ning YM, Pierce W, Maher VE, Karuri S, Tang SH, Chiu HJ, Palmby T, Zirkelbach JF, Marathe D, Mehrotra N, Liu Q, Ghosh D, Cottrell CL, Leighton J, Sridhara R, et al. Enzalutamide for treatment of patients with metastatic castration-resistant prostate cancer who have previously received docetaxel: U.S. Food and Drug Administration drug approval summary. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 6067-73. PMID 24141628 DOI: 10.1158/1078-0432.CCR-13-1763  0.44
2013 Herndon TM, Deisseroth A, Kaminskas E, Kane RC, Koti KM, Rothmann MD, Habtemariam B, Bullock J, Bray JD, Hawes J, Palmby TR, Jee J, Adams W, Mahayni H, Brown J, et al. U.s. Food and Drug Administration approval: carfilzomib for the treatment of multiple myeloma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 4559-63. PMID 23775332 DOI: 10.1158/1078-0432.CCR-13-0755  0.44
2013 Axelson M, Liu K, Jiang X, He K, Wang J, Zhao H, Kufrin D, Palmby T, Dong Z, Russell AM, Miksinski S, Keegan P, Pazdur R. U.S. Food and Drug Administration approval: vismodegib for recurrent, locally advanced, or metastatic basal cell carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 2289-93. PMID 23515405 DOI: 10.1158/1078-0432.CCR-12-1956  0.44
2013 Mikelis CM, Palmby TR, Simaan M, Li W, Szabo R, Lyons R, Martin D, Yagi H, Fukuhara S, Chikumi H, Galisteo R, Mukouyama YS, Bugge TH, Gutkind JS. PDZ-RhoGEF and LARG are essential for embryonic development and provide a link between thrombin and LPA receptors and Rho activation. The Journal of Biological Chemistry. 288: 12232-43. PMID 23467409 DOI: 10.1074/jbc.M112.428599  0.44
2010 Sakurai A, Gavard J, Annas-Linhares Y, Basile JR, Amornphimoltham P, Palmby TR, Yagi H, Zhang F, Randazzo PA, Li X, Weigert R, Gutkind JS. Semaphorin 3E initiates antiangiogenic signaling through plexin D1 by regulating Arf6 and R-Ras. Molecular and Cellular Biology. 30: 3086-98. PMID 20385769 DOI: 10.1128/MCB.01652-09  0.44
2010 Palmby TR, Rosenfeldt H, Gutkind JS. G-Protein-coupled receptors, signal fidelity, and cell transformation Handbook of Cell Signaling, 2/E. 2: 1635-1648. DOI: 10.1016/B978-0-12-374145-5.00201-1  0.44
2008 Tan W, Palmby TR, Gavard J, Amornphimoltham P, Zheng Y, Gutkind JS. An essential role for Rac1 in endothelial cell function and vascular development. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 1829-38. PMID 18245172 DOI: 10.1096/fj.07-096438  0.44
2008 Wolf J, Palmby TR, Gavard J, Williams BO, Gutkind JS. Multiple PPPS/TP motifs act in a combinatorial fashion to transduce Wnt signaling through LRP6. Febs Letters. 582: 255-61. PMID 18083125 DOI: 10.1016/j.febslet.2007.12.013  0.44
2004 Palmby TR, Abe K, Karnoub AE, Der CJ. Vav transformation requires activation of multiple GTPases and regulation of gene expression. Molecular Cancer Research : McR. 2: 702-11. PMID 15634759  0.44
2004 Singh A, Karnoub AE, Palmby TR, Lengyel E, Sondek J, Der CJ. Rac1b, a tumor associated, constitutively active Rac1 splice variant, promotes cellular transformation. Oncogene. 23: 9369-80. PMID 15516977 DOI: 10.1038/sj.onc.1208182  0.44
2002 Palmby TR, Abe K, Der CJ. Critical role of the pleckstrin homology and cysteine-rich domains in Vav signaling and transforming activity. The Journal of Biological Chemistry. 277: 39350-9. PMID 12177050 DOI: 10.1074/jbc.M202641200  0.44
2002 Wolfman JC, Palmby T, Der CJ, Wolfman A. Cellular N-Ras promotes cell survival by downregulation of Jun N-terminal protein kinase and p38. Molecular and Cellular Biology. 22: 1589-606. PMID 11839824 DOI: 10.1128/MCB.22.5.1589-1606.2002  0.44
Show low-probability matches.